Your shopping cart is currently empty

Bixin is an orally active carotenoid that modulates TLR4/NF-κB, Nrf2, and ROS to mitigate high-fat diet-induced cardiac injury in mice and induces apoptosis in A549, HeLa, and MCF-7 cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $77 | - | In Stock | |
| 5 mg | $197 | - | In Stock | |
| 10 mg | $313 | - | In Stock | |
| 25 mg | $528 | - | In Stock | |
| 50 mg | $752 | - | In Stock | |
| 100 mg | $987 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $169 | - | In Stock |
| Description | Bixin is an orally active carotenoid that modulates TLR4/NF-κB, Nrf2, and ROS to mitigate high-fat diet-induced cardiac injury in mice and induces apoptosis in A549, HeLa, and MCF-7 cells. |
| In vitro | Bixin (20-80 μM, 24 hours) not only ameliorated LPS-induced cellular fibrosis in H9C2 cells without cytotoxicity, but also alleviated inflammatory responses by inactivating the TLR4/NF-κB pathway and suppressed LPS-mediated ROS generation through activating the Nrf2 pathway [1]. Bixin (0-500 μM, 48 hours) exhibited anti-proliferative effects on three tumor cell lines: Human lung cancer (A549), cervical cancer (HeLa), and breast cancer (MCF-7) [2]. |
| In vivo | Bixin (50-200 mg/kg, orally administered once daily for 14 weeks) alleviates systemic inflammatory responses in a high-fat diet-induced mouse model by inhibiting the activation of the TLR4/NF-κB signaling pathway and reducing pro-inflammatory cytokine secretion. It also decreases ROS production through activation of the Nrf2 pathway while effectively ameliorating systemic metabolic disorder in mice [1]. |
| Molecular Weight | 394.50 |
| Formula | C25H30O4 |
| Cas No. | 6983-79-5 |
| Smiles | COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O |
| Relative Density. | 1.31g/cm3 |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 5.50 mg/mL (13.94 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.